Benign Prostatic Hyperplasia (BPH)

RSS | Login | Register

Prostatic Urethral Lift Relieves Lower Urinary Tract Symptoms

January 03, 2012

Use of a prostatic urethral lift procedure, a minimally invasive treatment for lower urinary tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH), preserves sexual function, according to a study published online ahead of print in The Journal of Sexual Medicine.

Study: Electromagnetic Treatment Improves BPH

Jody A. Charnow December 19, 2011

Radiofrequency pulsed electromagnetic fields (EMF) may provide a non-invasive treatment for benign prostatic hyperplasia (BPH), researchers reported.

Epinephrine Can Cut TURP-Related Blood Loss

Jody A. Charnow December 13, 2011

Epinephrine injected into the prostate can be used to decrease blood loss during transurethral resection of the prostate (TURP), according to researchers.

HoLEP's Benefits As BPH Treatment Durable Out to 10 Years

Stephan Cho October 31, 2011

Holmium laser enucleation of the prostate (HoLEP) is an effective treatment for benign prostatic hyperplasia (BPH) that has long-term durable clinical outcomes, researchers concluded.

Saw Palmetto No More Effective than Placebo for BPH

Delicia Honen Yard October 14, 2011

Saw palmetto fruit extracts are widely used to treat lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH), but a new study shows that these extracts are no better than placebo at easing symptoms, according to investigators.

Erectile Dysfunction Drug Approved as BPH Treatment

Jody A. Charnow October 08, 2011

The FDA has approved tadalafil (Cialis) for the once daily use as a treatment for benign prostatic hyperplasia (BPH). The agency also approved the medication for once daily use as a treatment for men with both erectile dysfunction (ED) and BPH.

Higher CRP Levels Predict Residual Urgency in BPH Patients

Jody A. Charnow August 31, 2011

GLASGOW—Serum C-reactive protein (CRP) levels, a marker of systemic inflammation, are associated with residual urgency after medical treatment for benign prostatic hyperplasia (BPH), according to new findings presented at the International Continence Society annual meeting.

Botulinum Toxin Injections Effective for BPH

Jody A. Charnow August 30, 2011

GLASGOW—Intraprostatic injections of botulinum neurotoxin type A (BoNT-A) are a safe and effective treatment for benign prostatic hyperplasia (BPH), according to a study presented at the International Continence Society annual meeting.

Heavier Men Face Higher LUTS Risk

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Elderly men who are overweight or obese are at increased risk for developing lower urinary tract symptoms (LUTS), but those who engage in a relatively high level of physical activity or daily walking for exercise have a reduced risk, data show.

Severe Adverse BPH Outcomes Persist

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Severe adverse outcomes of benign prostatic hyperplasia (BPH) persist despite widespread use of oral therapies, according to a study presented at the American Urological Association 2011 annual meeting.

Overweight Young Men Face High Risk of Enlarged Prostates

Jody A. Charnow May 17, 2011

WASHINGTON, D.C.—Overweight young men are more likely than normal-weight men to develop an enlarged prostate later in life, researchers reported.

Modest Weight Loss Does Not Prevent LUTS

Jody A. Charnow May 17, 2011

WASHINGTON, D.C.—Although obesity has been linked with lower urinary tract symptoms (LUTS) in aging men, modest weight loss may not prevent onset or progression of LUTS in this population, new findings presented at the American Urological Association 2011 annual meeting suggest.

Statins May Improve Urologic Symptoms in Men

Jody A. Charnow May 17, 2011

WASHINGTON, D.C.—Statin use may decrease the occurrence of lower urinary tract symptoms (LUTS) among men, but not women, researchers reported at the American Urological Association 2011 annual meeting.

African-American Men Less Likely to Receive BPH Treatment

Jody A. Charnow May 17, 2011

WASHINGTON, D.C.—African American men are less likely to receive treatment for benign prostatic hyperplasia (BPH) compared with other races, according to findings presented at the American Urological Association 2011 annual meeting.

Outpatient BPH Procedure Works

John Schieszer March 29, 2011

CHICAGO—Prostatic artery embolization (PAE), a new outpatient interventional radiology treatment that blocks the blood supply to enlarged prostate glands, achieves outcomes similar to those of transurethral resection of the prostate (TURP), according to Portuguese researchers.

Botulinum Toxin Eases LUTS in Men

Jody A. Charnow March 22, 2011

VIENNA—Botulinum toxin type A (BTA) injected into the prostate may be a safe and effective treatment for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to preliminary study results presented here at the 26th Annual Congress of the European Association of Urology.

Novel Cause of BPH, PCa Proposed

Jody A. Charnow March 22, 2011

VIENNA—Benign prostatic hyperplasia (BPH) and prostate cancer could be the result a previously unrecognized route of free testosterone flow from the testes to the prostate, according to investigators.

Tadalafil Helps Men with Both ED and BPH-LUTS

Jody A. Charnow March 20, 2011

VIENNA—Tadalafil can improve erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in men who suffer from both problems, data suggest.

AUA Updates BPH Guidelines

February 08, 2011

Updated American Urological Association (AUA) guidelines for treating benign prostatic hyperplasia (BPH) include recommendations that laboratory testing include a PSA test and a urinalysis to rule out infection or other causes of lower urinary tract symptoms (LUTS).

DHT Does Not Affect Prostate Growth

Delicia Honen Yard January 24, 2011

Dihydrotestosterone (DHT) treatment over two years does not halt prostate growth, according to study findings published in the Annals of Internal Medicine (2010;153:621-632).

Your Practice

Since its inception, health care providers have struggled with the need to protect patient privacy, share information, and keep paper work under control.

Read more on
Complying with HIPAA

Have any practice management topics that you'd like us to cover?
Let us know.

Legal Issues

Physician Sued For Failing to Follow Up

A primary care doctor referred a patient with an elevated PSA to a urologist. After a negative prostate biopsy, the doctor did not regularly conduct follow-up PSA testing, and the patient eventually died from prostate cancer.

Expert Q&A

The Lowdown on HIFU: An Interview with David Y.T. Chen, MD, FACS

Renal & Urology News asked urologic oncologist David Y.T. Chen, MD, FACS of Fox Chase Cancer Center in Philadelphia about his impressions of high-intensity focused ultrasound (HIFU) as an investigator in a trial featuring the treatment.